MARATTO

article · Bulletin of Pharmaceutical Sciences Assiut

The Contribution of Innate Immune Cells to the Pathophysiology of Acute Sterile Inflammation- Evidence from Preclinical Animal Models

2024Open accessMinia University

Abstract

One of the most critical factors for managing patients with liver disease is inflammation. The liver mediates numerous functions in the innate immunity, these functions predispose the liver to immunity-mediated liver injury if this inflammation is not checked. Models of sterile inflammation-related liver injury have witnessed significant attention during the last 25 years. Understanding the pathophysiology of acute sterile inflammation provides a clear vision about which mechanism is involved in this process. Many studies focused on developing and testing new therapeutic targets on different preclinical models of acute sterile inflammation with an ultimate goal of improving patient outcomes. In this review, we discuss the pathophysiology and the most common in vivo models of sterile inflammation. We then explain the most common innate immune cells that contribute to the development and progression of the disease. Finally, we discuss the interaction between these immune cells and the surrounding “niche” that favors their recruitment to the diseased livers.

Research topics

  • Atherosclerosis and Cardiovascular Diseases
  • IL-33, ST2, and ILC Pathways

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bfsa.2024.300889.2183

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.